Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-027878
Filing Date
2025-08-27
Accepted
2025-08-27 16:37:16
Documents
1
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6056
  Complete submission text file 0001437749-25-027878.txt   7456
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GLAUKOS CORPORATION 229 AVENIDA FABRICANTE SAN CLEMENTE CA 92672
Business Address
WEN LEANA (Reporting) CIK: 0001847598 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 251265829